ATE505202T1 - Immunologische methoden zur behandlung von gastrointestinalem krebs - Google Patents

Immunologische methoden zur behandlung von gastrointestinalem krebs

Info

Publication number
ATE505202T1
ATE505202T1 AT97905858T AT97905858T ATE505202T1 AT E505202 T1 ATE505202 T1 AT E505202T1 AT 97905858 T AT97905858 T AT 97905858T AT 97905858 T AT97905858 T AT 97905858T AT E505202 T1 ATE505202 T1 AT E505202T1
Authority
AT
Austria
Prior art keywords
treating gastrointestinal
gastrointestinal cancer
immunological methods
gastrin
amidated
Prior art date
Application number
AT97905858T
Other languages
English (en)
Inventor
Philip Gevas
Stephen Karr
Stephen Grimes
Dov Michaeli
Susan Watson
Original Assignee
Cancer Advances Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Advances Inc filed Critical Cancer Advances Inc
Application granted granted Critical
Publication of ATE505202T1 publication Critical patent/ATE505202T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/595—Gastrins; Cholecystokinins [CCK]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT97905858T 1996-02-08 1997-02-07 Immunologische methoden zur behandlung von gastrointestinalem krebs ATE505202T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1141196P 1996-02-08 1996-02-08
PCT/US1997/002029 WO1997028821A1 (en) 1996-02-08 1997-02-07 Immunological methods for the treatment of gastrointestinal cancer

Publications (1)

Publication Number Publication Date
ATE505202T1 true ATE505202T1 (de) 2011-04-15

Family

ID=21750270

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97905858T ATE505202T1 (de) 1996-02-08 1997-02-07 Immunologische methoden zur behandlung von gastrointestinalem krebs

Country Status (9)

Country Link
US (1) US20050025770A1 (de)
EP (1) EP0889735B1 (de)
JP (3) JP2000504692A (de)
AT (1) ATE505202T1 (de)
DE (1) DE69740173D1 (de)
DK (1) DK0889735T3 (de)
ES (1) ES2361474T3 (de)
PT (1) PT889735E (de)
WO (1) WO1997028821A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE505202T1 (de) * 1996-02-08 2011-04-15 Cancer Advances Inc Immunologische methoden zur behandlung von gastrointestinalem krebs
PT981369E (pt) * 1997-05-12 2005-03-31 Aphton Corp Composicoes imunogenicas para o receptor de cck-b/gastrina e metodos para o tratamento de tumores
US20040001842A1 (en) * 1997-05-12 2004-01-01 Dov Michaeli Immunogenic compositions to the CCK-B/gastrin receptor and methods for the treatment of tumors
CA2328501A1 (en) * 1998-05-15 1999-11-25 Aphton Corporation Prevention and treatment of hypergastrinemia
EP1897556A1 (de) * 1998-05-15 2008-03-12 Receptor Biologix, Inc. Vorbeugung und Behandlung von Hypergastrinämie
US20030068326A1 (en) * 1998-05-15 2003-04-10 Aphton Corporation Method for the treatment of gastroesophageal reflux disease
US20030091574A1 (en) * 2001-03-23 2003-05-15 Gevas Philip C. Combination treatment of pancreatic cancer
US20090191232A1 (en) * 2001-05-04 2009-07-30 Gevas Philip C Combination therapy for the treatment of tumors
KR20040049830A (ko) * 2001-07-09 2004-06-12 애프톤 코포레이션 간, 폐 및 식도의 암 및 전암 상태의 치료 및 예방
US20050169979A1 (en) * 2002-07-03 2005-08-04 Dov Michaeli Liposomal vaccine
WO2004088326A2 (en) * 2003-03-28 2004-10-14 Aphton Corporation Gastrin hormone immunoassays
WO2005095459A2 (en) * 2004-03-29 2005-10-13 Receptor Biologix, Inc. Monoclonal antibodies to gastrin hormone
WO2006032980A1 (en) * 2004-09-22 2006-03-30 Receptor Biologix, Inc. Monoclonal antibolies to progastrin
JP5558660B2 (ja) 2007-05-11 2014-07-23 日東電工株式会社 両面接着性感圧接着シート
US8674064B2 (en) * 2010-03-03 2014-03-18 Onkologix Ltd Immunogenic compositions against human progastrin peptides
CN101797382B (zh) 2010-03-03 2013-11-20 戚胜美 抗人前胃液素多肽免疫组合物
HUE037252T2 (hu) * 2013-05-21 2018-08-28 Tyg Oncology Ltd Gasztrin peptid immunogenikus kompozíció
US12150978B2 (en) 2017-06-15 2024-11-26 Cancer Advances Inc. Compositions and methods for preventing tumors and cancer
CN111050789A (zh) 2017-06-15 2020-04-21 癌症进展有限公司 用于诱导针对肿瘤和癌症的体液免疫和细胞免疫的组合物和方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US140962A (en) * 1873-07-15 Improvement in feeding paper to printing-presses
US21786A (en) * 1858-10-12 Improvement in the manufacture of sugar
US39911A (en) * 1863-09-15 Improvement in corset skirt-supporters
US91574A (en) * 1869-06-22 Improvement in water-closet valves
US95028A (en) * 1869-09-21 Improved process for preserving eggs
US68326A (en) * 1867-08-27 Alcibiades j
US187152A (en) * 1877-02-06 Improvement in clothes-wringers
US86941A (en) * 1869-02-16 Improvement in corn-planter
US69966A (en) * 1867-10-22 Joseph chadwick
US58040A (en) * 1866-09-18 Improvement in making bolts
US1842A (en) * 1840-10-31 Machine fob cutting corks
US20119A (en) * 1858-04-27 Improvement in raking and delivering attachments to harvesters
US4526716A (en) * 1981-11-20 1985-07-02 The Ohio State University Antigenic modification of polypeptides
US4384995A (en) * 1980-01-16 1983-05-24 The Ohio State University Antigenic modification of polypeptides
US4691006A (en) * 1983-03-04 1987-09-01 Ohio State University Antigenic modification of polypeptides
IT1179894B (it) * 1984-12-27 1987-09-16 Rotta Research Lab Proglumide e composizioni farmaceutiche che la contengono per l impiego nella terapia di affezioni neoplastiche
US6861510B1 (en) * 1989-01-24 2005-03-01 Aphton Corporation Immunogenic compositions against gastrin peptides
US5023077A (en) 1989-01-24 1991-06-11 Aphton Corporation Immunogenic compositions and methods for the treatment and prevention of gastric and duodenal ulcer disease
DK0380230T3 (da) * 1989-01-24 1995-01-16 Aphton Corp Immunogene sammensætninger mod gastrin-peptider
US5319073A (en) * 1992-02-07 1994-06-07 The United States Of America, As Represented By The Department Of Health & Human Services Method of purifying cholecystokinin receptor protein
US5759551A (en) * 1993-04-27 1998-06-02 United Biomedical, Inc. Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines
US5468494A (en) * 1993-11-12 1995-11-21 Aphton Corp. Immunogenic compositions against human gastrin 17
US5688506A (en) * 1994-01-27 1997-11-18 Aphton Corp. Immunogens against gonadotropin releasing hormone
FI97304C (fi) * 1994-11-16 1996-11-25 Locus Genex Oy Menetelmä mahasyövän riskin seulonnaksi
US6359114B1 (en) * 1995-06-07 2002-03-19 Aphton Corp. System for method for the modification and purification of proteins
ATE505202T1 (de) * 1996-02-08 2011-04-15 Cancer Advances Inc Immunologische methoden zur behandlung von gastrointestinalem krebs
PT981369E (pt) * 1997-05-12 2005-03-31 Aphton Corp Composicoes imunogenicas para o receptor de cck-b/gastrina e metodos para o tratamento de tumores
EP1154782A4 (de) * 1999-02-24 2002-09-25 Uab Research Foundation Taxan derivate zur zielgerichteten krebstherapy

Also Published As

Publication number Publication date
US20050025770A1 (en) 2005-02-03
JP5200269B2 (ja) 2013-06-05
JP5200251B2 (ja) 2013-06-05
JP2000504692A (ja) 2000-04-18
JP2012097062A (ja) 2012-05-24
EP0889735B1 (de) 2011-04-13
ES2361474T3 (es) 2011-06-17
JP2007126461A (ja) 2007-05-24
WO1997028821A1 (en) 1997-08-14
DE69740173D1 (de) 2011-05-26
EP0889735A1 (de) 1999-01-13
PT889735E (pt) 2011-07-19
DK0889735T3 (da) 2011-08-08

Similar Documents

Publication Publication Date Title
ATE505202T1 (de) Immunologische methoden zur behandlung von gastrointestinalem krebs
AU600466B2 (en) Htlv-iii envelope peptides
DE50310283D1 (de) Verfahren zur identifizierung von immunreaktiven peptiden
DK532284A (da) Fremgangsmaade til bestemmelse af antigenaktive aminosyresekvenser
WO1997028821B1 (en) Immunological methods for the treatment of gastrointestinal cancer
NZ237666A (en) Hiv envelope (env) polypeptides, antibodies and compositions for treating aids
DE69129302D1 (de) Inhibitoren des tumorwachstums aus geweben, methoden ihrer herstellung und verwendungen
ZA945364B (en) Antibodies specific for human prostate glandular kallikrein
BR9707819A (pt) Imunogenos peptidicos
DE69942742D1 (de) Immuntherapeutische zusammensetzung und verfahren zur behandlung von prostatakrebs
BR9809656A (pt) Composição imunopotencializante
GR3018371T3 (en) Method for identifying or determining proteins and applications therefor.
JPS6470498A (en) Synthetic peptide and antibody thereto
GB9509620D0 (en) Transepithelial transport of molecular species
DK0991945T3 (da) Fremgangsmåde til identifikation af tumor-antigener med antistoffer i serum
EP0420848A4 (en) Carcinoma-associated antigens, and antibodies which recognize these antigens
SE0002835D0 (sv) Method and kit for production of monoclonal antibodies
DE3883808D1 (de) Testsatz, Extraktionsvorrichtung und Verfahren zur Bestimmung von Streptococcus-A-Antigen.
EP0734451A4 (de) Enterotoxine aus -i(shigella flexneri)
ATE143146T1 (de) Verfahren und reagenz zur bestimmung des follikel stimulierenden hormons sowie hierzu geeignete monoklonale antikörper
ATE258684T1 (de) Vorrichtung zur prozessierung von analyten an festphasen
DE3685564D1 (de) Verfahren zur herstellung von ultrareinem siliziumnitrid-/oxynitridpulver.
HUP9904404A1 (hu) Eljárás laphám-karcinómák diagnosztizálására és kezelésére
DE69716728D1 (de) Zytofluorometrisches verfahren zur bestimmung von antikörper gegen tumorantigene im serum
SE8205746D0 (sv) Julgransmatta

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0889735

Country of ref document: EP